Interleukin-1β 유전자 내 -511C/T 단일염기다형성과 유방암 관련 우울증 = Interleukin-1β -511C/T Gene Polymorphism and Depression Related to Breast Cancer

다국어 초록 (Multilingual Abstract)

Objectives : Pro-inflammatory cytokines are related to the pathophysiology of both cancer and depression, and their secretion is controlled by the transcriptional activity of particular gene polymorphisms. This study aimed to investigate whether interleukin (IL)-1β -511C/T gene polymorphism is associated with depression following mastectomy for breast cancer. Methods : A total of 309 patients with breast cancer were evaluated one week after mastectomy, and 244 (79%) were followed one year later. Depression (major+minor depressive disorders) was diagnosed according to DSM-IV criteria using the Mini International Neuropsychiatric Interview, and classified into prevalent, persistent, and incident depression. Associations of IL-1β -511C/T polymorphism with the three depressive status were estimated using logistic regression models. Results : At baseline, 74 (24%) patients were classified with prevalent depression ; and at follow up, 19 (8%) and 25 (10%) patients were classified with persistent and incident depression, respectively. The IL-1β -511T/T genotype was independently associated with prevalent and persistent depression, but not with incident depression. Conclusion : IL-1β -511T/T genotype may involve in the etiology of depression occurring in women with breast cancer who receive a mastectomy. (J of Kor Soc for Dep and Bip Disorders 2011;9:189-193)

참고문헌 (Reference)

1 Yoo SW, "Validity of Korean version of the Mini-International Neuropsychiatric Interview" 2 : 50-55, 2006

2 Babcock TA, "Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells" 12 : 588-594, 2000

3 Sheehan DV, "The mini-international neuropsychiatric interview (M.I. N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-VI and ICD-10" 59 : 22-33, 1988

4 Kendler KS, "The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression" 62 : 529-535, 2005

5 Massie MJ, "Prevalence of depression in patients with cancer" 32 : 57-71, 2004

6 Cho MJ, "Lifetime and 12month prevalence of DSM-IV psychiatric disorder among Korean adults" 195 : 203-210, 2007

7 Soygur H, "Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder" 31 : 1242-1247, 2007

8 Rosa A, "Interleukin-1β (IL-1β) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders" 124 : 10-14, 2004

9 Hamacher R, "Interleukin 1 beta gene promoter SNPs are associated with risk of pancreatic cancer" 46 : 182-186, 2009

10 Kim JM, "Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders" 62 : 423-428, 2007

11 Musselman DL, "Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings" 158 : 1252-1257, 2001

12 de Craen AJ, "Heritability estimates of innate immunity: an extended twin study" 6 : 167-170, 2005

13 Ferlay J, "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008" 127 : 2893-2917, 2010

14 Shim EJ, "Distress and its correlates in Korean cancer patients: Pilot use of the distress thermometer and the problem list" John Wiley & Sons Inc. 17 (17): 548-555, 200806

15 American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" American Psychiatric Press 1994

16 Reich M, "Depression, quality of life and breast cancer: a review of the literature" 110 : 9-17, 2008

17 Spiegel D, "Depression and cancer: mechanisms and disease progression" 54 : 269-282, 2003

18 Giese-Davis J, "Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis" 29 : 413-420, 2011

19 Seruga B, "Cytokines and their relationship to the symptoms and outcome of cancer" 8 : 887-899, 2008

20 Schiepers OJ, "Cytokines and major depression" 29 : 201-217, 2005

21 Jemal A, "Cancer statistics" 60 : 277-300, 2010

22 Bower J, "Behavioral symptoms in patients with breast cancer and survivors" 26 : 768-777, 2008

23 Yu YW, "Association study of the interleukin-1β (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response" 28 : 1182-1185, 2003

24 Mattila KM, "Association of an interleukin 1B gene polymorphism (_511) with Parkinson’s disease in Finnish patients" 39 : 400-402, 2002

25 Liu YH, "Association of Interleukin-1β (IL1B) Polymorphisms with Graves’ Ophthalmopathy in Taiwan Chinese Patients" 51 : 6238-6246, 2010

26 McCulley MC, "Association between interleukin 1-β promoter (-511) polymorphism and depressive symptoms in Alzheimer’s disease" 124 : 50-53, 2004

27 American Joint Committee on Cancer (AJCC), "AJCC cancer staging handbook from the AJCC cancer staging manual" Springer-Verlag 257-281, 2002